Rapport Therapeutics, Inc. Common Stock
RAPP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $11,266 | $4,030 | $1,935 | $3,422 |
| - Cash | $251 | $55 | $58 | $57 |
| + Debt | $12 | $12 | $8 | $1 |
| Enterprise Value | $11,026 | $3,987 | $1,885 | $3,366 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$27 | -$29 | -$27 | -$23 |
| % Margin | – | – | – | – |
| Net Income | -$27 | -$27 | -$24 | -$20 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.71 | -0.75 | -0.12 | -0.1 |
| % Growth | 5.3% | -525% | -20% | – |
| Operating Cash Flow | -$17 | -$25 | -$20 | -$14 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$18 | -$25 | -$21 | -$15 |